318 related articles for article (PubMed ID: 26834735)
41. TGF-β-dependent induction of CD4⁺CD25⁺Foxp3⁺ Tregs by liver sinusoidal endothelial cells.
Carambia A; Freund B; Schwinge D; Heine M; Laschtowitz A; Huber S; Wraith DC; Korn T; Schramm C; Lohse AW; Heeren J; Herkel J
J Hepatol; 2014 Sep; 61(3):594-9. PubMed ID: 24798620
[TBL] [Abstract][Full Text] [Related]
42. Human memory Helios- FOXP3+ regulatory T cells (Tregs) encompass induced Tregs that express Aiolos and respond to IL-1β by downregulating their suppressor functions.
Raffin C; Pignon P; Celse C; Debien E; Valmori D; Ayyoub M
J Immunol; 2013 Nov; 191(9):4619-27. PubMed ID: 24068664
[TBL] [Abstract][Full Text] [Related]
43. FOXP3+ regulatory T cells: control of FOXP3 expression by pharmacological agents.
Ohkura N; Hamaguchi M; Sakaguchi S
Trends Pharmacol Sci; 2011 Mar; 32(3):158-66. PubMed ID: 21237521
[TBL] [Abstract][Full Text] [Related]
44. Regulatory T cells in renal disease.
Wang YM; Hu M; Wang Y; Polhill T; Zhang GY; Wang Y; Lee VW; Harris DC; Alexander SI
Int J Clin Exp Med; 2008; 1(4):294-304. PubMed ID: 19079673
[TBL] [Abstract][Full Text] [Related]
45. Genetic Engineering of T Cells for Immune Tolerance.
Scott DW
Mol Ther Methods Clin Dev; 2020 Mar; 16():103-107. PubMed ID: 31934598
[TBL] [Abstract][Full Text] [Related]
46. Recent Advances in Cell Therapeutics for Systemic Autoimmune Diseases.
Park Y; Kwok SK
Immune Netw; 2022 Feb; 22(1):e10. PubMed ID: 35291648
[TBL] [Abstract][Full Text] [Related]
47. How deep can you go into Tregs?
Scheinberg P
Blood; 2016 Sep; 128(9):1158-9. PubMed ID: 27587862
[No Abstract] [Full Text] [Related]
48. Tregitopes switch on Tregs.
Caspi RR
Blood; 2008 Oct; 112(8):3003-4. PubMed ID: 18840719
[TBL] [Abstract][Full Text] [Related]
49. Harnessing the plasticity of CD4(+) T cells to treat immune-mediated disease.
DuPage M; Bluestone JA
Nat Rev Immunol; 2016 Mar; 16(3):149-63. PubMed ID: 26875830
[TBL] [Abstract][Full Text] [Related]
50. Regulatory T cell therapy for type 1 diabetes: May the force be with you.
Gitelman SE; Bluestone JA
J Autoimmun; 2016 Jul; 71():78-87. PubMed ID: 27133597
[TBL] [Abstract][Full Text] [Related]
51. Tregalizumab - A Monoclonal Antibody to Target Regulatory T Cells.
König M; Rharbaoui F; Aigner S; Dälken B; Schüttrumpf J
Front Immunol; 2016; 7():11. PubMed ID: 26834751
[TBL] [Abstract][Full Text] [Related]
52. CD28 Costimulation: From Mechanism to Therapy.
Esensten JH; Helou YA; Chopra G; Weiss A; Bluestone JA
Immunity; 2016 May; 44(5):973-88. PubMed ID: 27192564
[TBL] [Abstract][Full Text] [Related]
53. Avidity and Bystander Suppressive Capacity of Human Regulatory T Cells Expressing
Yeh WI; Seay HR; Newby B; Posgai AL; Moniz FB; Michels A; Mathews CE; Bluestone JA; Brusko TM
Front Immunol; 2017; 8():1313. PubMed ID: 29123516
[TBL] [Abstract][Full Text] [Related]
54. Polyclonal Regulatory T Cell Therapy for Control of Inflammation in Kidney Transplants.
Chandran S; Tang Q; Sarwal M; Laszik ZG; Putnam AL; Lee K; Leung J; Nguyen V; Sigdel T; Tavares EC; Yang JYC; Hellerstein M; Fitch M; Bluestone JA; Vincenti F
Am J Transplant; 2017 Nov; 17(11):2945-2954. PubMed ID: 28675676
[TBL] [Abstract][Full Text] [Related]
55. Kinome Profiling of Regulatory T Cells: A Closer Look into a Complex Intracellular Network.
Tuettenberg A; Hahn SA; Mazur J; Gerhold-Ay A; Scholma J; Marg I; Ulges A; Satoh K; Bopp T; Joore J; Jonuleit H
PLoS One; 2016; 11(2):e0149193. PubMed ID: 26881744
[TBL] [Abstract][Full Text] [Related]
56. Transplant trials with Tregs: perils and promises.
Tang Q; Vincenti F
J Clin Invest; 2017 Jun; 127(7):2505-2512. PubMed ID: 28665300
[TBL] [Abstract][Full Text] [Related]
57. Expansion of Human Tregs from Cryopreserved Umbilical Cord Blood for GMP-Compliant Autologous Adoptive Cell Transfer Therapy.
Seay HR; Putnam AL; Cserny J; Posgai AL; Rosenau EH; Wingard JR; Girard KF; Kraus M; Lares AP; Brown HL; Brown KS; Balavage KT; Peters LD; Bushdorf AN; Atkinson MA; Bluestone JA; Haller MJ; Brusko TM
Mol Ther Methods Clin Dev; 2017 Mar; 4():178-191. PubMed ID: 28345003
[TBL] [Abstract][Full Text] [Related]
58. Engineering Therapeutic T Cells: From Synthetic Biology to Clinical Trials.
Esensten JH; Bluestone JA; Lim WA
Annu Rev Pathol; 2017 Jan; 12():305-330. PubMed ID: 27959633
[TBL] [Abstract][Full Text] [Related]
59. T regulatory cell chemokine production mediates pathogenic T cell attraction and suppression.
Patterson SJ; Pesenacker AM; Wang AY; Gillies J; Mojibian M; Morishita K; Tan R; Kieffer TJ; Verchere CB; Panagiotopoulos C; Levings MK
J Clin Invest; 2016 Mar; 126(3):1039-51. PubMed ID: 26854929
[TBL] [Abstract][Full Text] [Related]
60. What is wrong with the regulatory T cells and foetomaternal tolerance in women with recurrent miscarriages?
Craenmehr MH; Heidt S; Eikmans M; Claas FH
HLA; 2016 Feb; 87(2):69-78. PubMed ID: 26841054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
